
David Guzo
Examiner (ID: 9040)
| Most Active Art Unit | 1636 |
| Art Unit(s) | 1636, 1805, 2899 |
| Total Applications | 1205 |
| Issued Applications | 693 |
| Pending Applications | 160 |
| Abandoned Applications | 352 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7269928
[patent_doc_number] => 20040058446
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-25
[patent_title] => 'Compositions and methods for drug delivery using pH sensitive molecules'
[patent_app_type] => new
[patent_app_number] => 10/619778
[patent_app_country] => US
[patent_app_date] => 2003-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40340
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20040058446.pdf
[firstpage_image] =>[orig_patent_app_number] => 10619778
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/619778 | Compositions and methods for drug delivery using pH sensitive molecules | Jul 14, 2003 | Issued |
Array
(
[id] => 7034331
[patent_doc_number] => 20050032841
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-10
[patent_title] => 'Therapeutic compositions and methods of treating glycolipid storage related disorders'
[patent_app_type] => utility
[patent_app_number] => 10/619378
[patent_app_country] => US
[patent_app_date] => 2003-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 13154
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20050032841.pdf
[firstpage_image] =>[orig_patent_app_number] => 10619378
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/619378 | Therapeutic compositions and methods of treating glycolipid storage related disorders | Jul 13, 2003 | Abandoned |
Array
(
[id] => 7033710
[patent_doc_number] => 20050032220
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-10
[patent_title] => 'Amplifiable adeno-associated virus (AAV) packaging cassettes for the production of recombinant AAV vectors'
[patent_app_type] => utility
[patent_app_number] => 10/615119
[patent_app_country] => US
[patent_app_date] => 2003-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 18077
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20050032220.pdf
[firstpage_image] =>[orig_patent_app_number] => 10615119
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/615119 | Amplifiable adeno-associated virus (AAV) packaging cassettes for the production of recombinant AAV vectors | Jul 6, 2003 | Abandoned |
Array
(
[id] => 7061184
[patent_doc_number] => 20050003545
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-06
[patent_title] => 'Adenovirus packaging cell lines'
[patent_app_type] => utility
[patent_app_number] => 10/613106
[patent_app_country] => US
[patent_app_date] => 2003-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10823
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20050003545.pdf
[firstpage_image] =>[orig_patent_app_number] => 10613106
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/613106 | Adenovirus packaging cell lines | Jul 2, 2003 | Issued |
Array
(
[id] => 7269897
[patent_doc_number] => 20040058415
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-25
[patent_title] => 'Overexpression of aminoacyl-tRNA synthetases for efficient production of engineered proteins containing amino acid analogues'
[patent_app_type] => new
[patent_app_number] => 10/612713
[patent_app_country] => US
[patent_app_date] => 2003-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 20959
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20040058415.pdf
[firstpage_image] =>[orig_patent_app_number] => 10612713
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/612713 | Overexpression of aminoacyl-tRNA synthetases for efficient production of engineered proteins containing amino acid analogues | Jun 30, 2003 | Issued |
Array
(
[id] => 7203336
[patent_doc_number] => 20040087027
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-06
[patent_title] => 'Recombinant adenoviral vector and methods of use'
[patent_app_type] => new
[patent_app_number] => 10/602258
[patent_app_country] => US
[patent_app_date] => 2003-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 16744
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20040087027.pdf
[firstpage_image] =>[orig_patent_app_number] => 10602258
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/602258 | Recombinant adenoviral vector and methods of use | Jun 22, 2003 | Abandoned |
Array
(
[id] => 5091664
[patent_doc_number] => 20070231303
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-04
[patent_title] => 'METHODS OF GENERATING CHIMERIC ADENOVIRUSES AND USES FOR SUCH CHIMERIC ADENOVIRUSES'
[patent_app_type] => utility
[patent_app_number] => 10/465302
[patent_app_country] => US
[patent_app_date] => 2003-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19980
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0231/20070231303.pdf
[firstpage_image] =>[orig_patent_app_number] => 10465302
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/465302 | Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses | Jun 19, 2003 | Issued |
Array
(
[id] => 1052878
[patent_doc_number] => 06858205
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-02-22
[patent_title] => 'GP64-null baculoviruses pseudotyped with heterologous envelope proteins for gene therapy'
[patent_app_type] => utility
[patent_app_number] => 10/600900
[patent_app_country] => US
[patent_app_date] => 2003-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 8140
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/858/06858205.pdf
[firstpage_image] =>[orig_patent_app_number] => 10600900
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/600900 | GP64-null baculoviruses pseudotyped with heterologous envelope proteins for gene therapy | Jun 19, 2003 | Issued |
Array
(
[id] => 435770
[patent_doc_number] => 07262025
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-08-28
[patent_title] => 'Hybrid vector having a cytomegalovirus enhancer and myeloproliferative sarcoma virus promoter'
[patent_app_type] => utility
[patent_app_number] => 10/465156
[patent_app_country] => US
[patent_app_date] => 2003-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10318
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/262/07262025.pdf
[firstpage_image] =>[orig_patent_app_number] => 10465156
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/465156 | Hybrid vector having a cytomegalovirus enhancer and myeloproliferative sarcoma virus promoter | Jun 17, 2003 | Issued |
Array
(
[id] => 7314275
[patent_doc_number] => 20040033978
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-19
[patent_title] => 'Compositions and methods for treatment of Hepatitis C virus-associated diseases'
[patent_app_type] => new
[patent_app_number] => 10/457304
[patent_app_country] => US
[patent_app_date] => 2003-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25115
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0033/20040033978.pdf
[firstpage_image] =>[orig_patent_app_number] => 10457304
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/457304 | Compositions and methods for treatment of Hepatitis C virus-associated diseases | Jun 8, 2003 | Abandoned |
Array
(
[id] => 7433213
[patent_doc_number] => 20040002158
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-01
[patent_title] => 'Long term expression of lentiviral vectors'
[patent_app_type] => new
[patent_app_number] => 10/455080
[patent_app_country] => US
[patent_app_date] => 2003-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4385
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0002/20040002158.pdf
[firstpage_image] =>[orig_patent_app_number] => 10455080
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/455080 | Long term expression of lentiviral vectors | Jun 4, 2003 | Abandoned |
Array
(
[id] => 5075263
[patent_doc_number] => 20070015238
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-18
[patent_title] => 'Production of pseudotyped recombinant AAV virions'
[patent_app_type] => utility
[patent_app_number] => 10/456423
[patent_app_country] => US
[patent_app_date] => 2003-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10280
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20070015238.pdf
[firstpage_image] =>[orig_patent_app_number] => 10456423
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/456423 | Production of pseudotyped recombinant AAV virions | Jun 4, 2003 | Abandoned |
Array
(
[id] => 7356566
[patent_doc_number] => 20040049021
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-11
[patent_title] => 'Compositions and mehtods for treatment of Hepatitis C virus-associated diseases'
[patent_app_type] => new
[patent_app_number] => 10/454293
[patent_app_country] => US
[patent_app_date] => 2003-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23744
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20040049021.pdf
[firstpage_image] =>[orig_patent_app_number] => 10454293
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/454293 | Compositions and mehtods for treatment of Hepatitis C virus-associated diseases | Jun 3, 2003 | Abandoned |
Array
(
[id] => 7289589
[patent_doc_number] => 20040110295
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-10
[patent_title] => 'Nucleic acid vectors'
[patent_app_type] => new
[patent_app_number] => 10/446629
[patent_app_country] => US
[patent_app_date] => 2003-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 56529
[patent_no_of_claims] => 78
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20040110295.pdf
[firstpage_image] =>[orig_patent_app_number] => 10446629
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/446629 | Nucleic acid vectors | May 27, 2003 | Abandoned |
Array
(
[id] => 7134969
[patent_doc_number] => 20040043490
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-04
[patent_title] => 'Cells to be used in producing virus vector, process for producing the same, and process for producing virus vector with the use of the cells'
[patent_app_type] => new
[patent_app_number] => 10/432467
[patent_app_country] => US
[patent_app_date] => 2003-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6053
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0043/20040043490.pdf
[firstpage_image] =>[orig_patent_app_number] => 10432467
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/432467 | Cells to be used in producing virus vector, process for producing the same, and process for producing virus vector with the use of the cells | May 20, 2003 | Abandoned |
Array
(
[id] => 7202190
[patent_doc_number] => 20040086900
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-06
[patent_title] => 'Cloning of mammalian genes in microbial organisms and methods for pharmacological screening'
[patent_app_type] => new
[patent_app_number] => 10/442675
[patent_app_country] => US
[patent_app_date] => 2003-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10066
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20040086900.pdf
[firstpage_image] =>[orig_patent_app_number] => 10442675
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/442675 | Cloning of mammalian genes in microbial organisms and methods for pharmacological screening | May 20, 2003 | Abandoned |
Array
(
[id] => 7295836
[patent_doc_number] => 20040214158
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-28
[patent_title] => 'Treatment of human papillomavirus (hpv)-infected cells'
[patent_app_type] => new
[patent_app_number] => 10/276076
[patent_app_country] => US
[patent_app_date] => 2003-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 17674
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20040214158.pdf
[firstpage_image] =>[orig_patent_app_number] => 10276076
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/276076 | Treatment of human papillomavirus (hpv)-infected cells | May 19, 2003 | Abandoned |
Array
(
[id] => 7394469
[patent_doc_number] => 20040038404
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-26
[patent_title] => 'Recombinant adenoviral vector and methods of use'
[patent_app_type] => new
[patent_app_number] => 10/441510
[patent_app_country] => US
[patent_app_date] => 2003-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 16664
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20040038404.pdf
[firstpage_image] =>[orig_patent_app_number] => 10441510
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/441510 | Recombinant adenoviral vector and methods of use | May 18, 2003 | Issued |
Array
(
[id] => 6809155
[patent_doc_number] => 20030199094
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-23
[patent_title] => 'Assays for beta-amyloid processing'
[patent_app_type] => new
[patent_app_number] => 10/437706
[patent_app_country] => US
[patent_app_date] => 2003-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 14016
[patent_no_of_claims] => 86
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0199/20030199094.pdf
[firstpage_image] =>[orig_patent_app_number] => 10437706
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/437706 | Assays for beta-amyloid processing | May 13, 2003 | Abandoned |
Array
(
[id] => 6977446
[patent_doc_number] => 20050287162
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-29
[patent_title] => 'Recombinant fowlpox virus'
[patent_app_type] => utility
[patent_app_number] => 10/514056
[patent_app_country] => US
[patent_app_date] => 2003-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8876
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20050287162.pdf
[firstpage_image] =>[orig_patent_app_number] => 10514056
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/514056 | Recombinant fowlpox virus | May 12, 2003 | Abandoned |